Lu Yang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Sentinel Lymph Node

Top Venues

Briefings in bioinformatics

Bioinformatics (Oxford, England)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Lu Yang, Pei Wang, Jun Chen
2dGBH: Two-dimensional group Benjamini-Hochberg procedure for false discovery rate control in two-way multiple testing of genomic data. Bioinformatics (Oxford, England) 40 (2) (2024)
Tina J Hieken, Garth D Nelson, Thomas J Flotte, Eric P Grewal, Jun Chen, Robert R McWilliams, Lisa A Kottschade, Lu Yang, Evidio Domingo-Musibay, Roxana S Dronca, Yiyi Yan, Svetomir N Markovic, Anastasios Dimou, Heather N Montane, Courtney L Erskine, Mara A Piltin, Daniel L Price, Samir S Khariwala, Jane Yuet Ching Hui, Carrie A Strand, Susan M Harrington, Vera J Suman, Haidong Dong, Matthew S Block
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial. Nature communications 15 (1) (2024)
Lu Yang, Pei Wang, Jun Chen
2dGBH: Two-dimensional group Benjamini-Hochberg procedure for false discovery rate control in two-way multiple testing of genomic data. Bioinformatics (Oxford, England) 40 (2) (2024)
Lu Yang, Pei Wang, Jun Chen
2dGBH: Two-dimensional group Benjamini-Hochberg procedure for false discovery rate control in two-way multiple testing of genomic data. Bioinformatics (Oxford, England) 40 (2) (2024)
Tina J Hieken, Garth D Nelson, Thomas J Flotte, Eric P Grewal, Jun Chen, Robert R McWilliams, Lisa A Kottschade, Lu Yang, Evidio Domingo-Musibay, Roxana S Dronca, Yiyi Yan, Svetomir N Markovic, Anastasios Dimou, Heather N Montane, Courtney L Erskine, Mara A Piltin, Daniel L Price, Samir S Khariwala, Jane Yuet Ching Hui, Carrie A Strand, Susan M Harrington, Vera J Suman, Haidong Dong, Matthew S Block
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial. Nature communications 15 (1) (2024)
Guanxun Li, Lu Yang, Jun Chen, Xianyang Zhang
Robust Differential Abundance Analysis of Microbiome Sequencing Data. Genes 14 (11) (2023)
Lu Yang, Jun Chen
Benchmarking differential abundance analysis methods for correlated microbiome sequencing data. Briefings in bioinformatics 24 (1) (2023)
Lu Yang, Jun Chen
Benchmarking differential abundance analysis methods for correlated microbiome sequencing data. Briefings in bioinformatics 24 (1) (2023)
Lu Yang, Jun Chen
Benchmarking differential abundance analysis methods for correlated microbiome sequencing data. Briefings in bioinformatics (2023)